EHMT2 and neoplasm: Of note, a recent report surprisingly demonstrated enhanced tumor formation when initiating tumors with mutant Kras and EHMT2 knockdown (Rowbotham et al., 2018), This is in direct contradiction to our findings using a genetic model to delete EHMT2 concurrent with KrasG12D in tumor initiation.